Use of ribofuranose derivatives against inflammatory bowel diseases
First Claim
1. A method of treatment [or prophylaxis] of an inflammatory bowel disease in a subject in need of said treatment [or prophylaxis], said method comprising:
- providing one or more ribofuranose derivatives having the Formula (I);
wherein R is a group selected from the group consisting of a carboxamide, an amidine and pharmaceutically acceptable acid addition salts thereof and the configuration at the C2 carbon of the ribofuranose moiety is [D or] L; and
administering said one or more ribofuranose derivatives to said subject in an amount effective to treat [or revent] said inflammatory bowel disease.
9 Assignments
0 Petitions
Accused Products
Abstract
A method for the prophylaxis or treatment of an inflammatory bowel disease is provided, comprising administering to a patient having or at risk of developing an inflammatory bowel disease a therapeutically or preventatively effective amount of one or more ribofuranose derivatives having the Formula (I):
wherein R is a group selected from a carboxamide, an amidine, and pharmaceutically acceptable acid addition salts thereof, and the configuration at the C2 carbon of the ribofuranose moiety is D or L. The one or more ribofuranose derivatives (I) may be used in combination with further active agents such as antivirals or agents effective against inflammatory bowel disease.
33 Citations
16 Claims
-
1. A method of treatment [or prophylaxis] of an inflammatory bowel disease in a subject in need of said treatment [or prophylaxis], said method comprising:
-
providing one or more ribofuranose derivatives having the Formula (I);
wherein R is a group selected from the group consisting of a carboxamide, an amidine and pharmaceutically acceptable acid addition salts thereof and the configuration at the C2 carbon of the ribofuranose moiety is [D or] L; and administering said one or more ribofuranose derivatives to said subject in an amount effective to treat [or revent] said inflammatory bowel disease. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)
-
Specification